---

Ventricular Fibrillation (VF) - Complete MBBS/NEET PG Study Guide

---

1. Definition of Ventricular Fibrillation

• Ventricular rate: 300-500 disorganized impulses per minute (no true "rate" - just chaos)
• There is no identifiable P wave, QRS complex, or T wave
• The result is the same as cardiac standstill: no blood is pumped

"The most serious of all cardiac arrhythmias is ventricular fibrillation, which is almost invariably fatal if not stopped within 1 to 3 minutes." - Guyton & Hall Medical Physiology

---

2. Normal Cardiac Electrical Conduction and How VF Develops

Normal conduction (the baseline you need to know):

SA Node (60-100 bpm)
    ↓
Atrial myocardium (P wave on ECG)
    ↓
AV Node (physiologic delay - allows atria to empty)
    ↓
Bundle of His
    ↓
Left Bundle Branch + Right Bundle Branch
    ↓
Purkinje Fibers (rapid spread - narrow QRS)
    ↓
Ventricular myocardium contracts uniformly (QRS complex)
    ↓
Repolarization (T wave)
    ↓ 
Refractoriness → impulse dies → waits for next SA node firing

How VF Develops - The Reentry Mechanism

1. Long pathway - dilated cardiomyopathy, hypertrophied hearts - by the time the impulse completes the circuit, tissue ahead is no longer refractory
2. Slow conduction velocity - ischemia, Purkinje system block, high K+ - the impulse arrives at tissue that has already recovered
3. Shortened refractory period - sympathetic stimulation, drugs (epinephrine, certain anti-arrhythmics) - tissue recovers very quickly, the impulse re-enters too soon

---

3. Etiology and Risk Factors

Cardiac Causes (most common)

Non-Cardiac Causes

---

4. Pathophysiology - Step by Step

• Creates areas of slow conduction (ischemic cells have low resting membrane potential)
• Creates non-uniform refractoriness (some areas recover faster than others)
• Shortens action potential duration in some cells, lengthens in others → dispersion of refractoriness

• 0-4 seconds: Awareness lost
• 4-5 seconds: Unconsciousness
• 10-20 seconds: Seizure-like activity (agonal)
• 4-6 minutes: Irreversible brain damage begins

• 10 minutes without CPR: Near-zero survival

---

5. ECG Features of VF with Detailed Interpretation

The ECG of VF (Guyton & Hall):

"The ECG is bizarre and ordinarily shows no tendency toward a regular rhythm of any type."

ECG Interpretation Points for Exams:

1. No identifiable QRS complex - this single feature is the most important
2. No isoelectric baseline - the tracing never returns to a flat line
3. Chaotic, random deflections - vary continuously in amplitude, frequency, and morphology
4. During first few seconds: larger amplitude waves (coarse VF) as large masses contract
5. After 20-30 seconds: amplitude decays to 0.2-0.3 mV
6. After depletion: minute voltages of 0.1 mV or less can persist for 10+ minutes

---

6. Clinical Features and Presentation

• Sudden collapse
• Patient may cry out as respiratory muscles contract
• Possible prodrome: chest pain (in ischemia-triggered VF), palpitations, presyncope

• Unresponsive - no verbal response, no purposeful movement
• Apneic or agonal breathing (gasping - do not mistake this for normal breathing)
• Pulseless - no carotid or femoral pulse
• No heart sounds on auscultation
• Skin: rapidly becomes pale, then cyanotic

• Fixed and dilated pupils (brain hypoxia)
• Seizure-like movements (agonal)
• Loss of all brainstem reflexes

---

7. Types of VF: Coarse vs Fine VF

Coarse VF

• Amplitude: > 0.2 mV (large, prominent undulations)
• Appearance: Large, irregular waves easily visible
• Significance: Occurs earlier in VF, myocardium still has some energy reserves (ATP)
• Prognosis: Better - more amenable to defibrillation
• Clinical implication: More likely to convert with first shock

Fine VF

• Amplitude: < 0.2 mV (small, barely perceptible waves)
• Appearance: Near-flat line with tiny irregular undulations
• Significance: Occurs later - energy-depleted myocardium
• Prognosis: Worse - difficult to defibrillate; can be mistaken for asystole
• Clinical implication: CPR first (to restore some perfusion) before defibrillation attempt

Exam Distinction:

---

8. Diagnosis and Differential Diagnosis

Diagnosis:

1. Clinical: Sudden unresponsiveness + pulselessness + apnea
2. ECG: Chaotic, irregular undulations without QRS complexes
3. Always confirm in two leads before treating

Differential Diagnosis of "No Pulse + Abnormal ECG":

Differential for the ECG pattern of VF:

• Artifact (electrode displacement, patient movement) - can perfectly mimic VF; check the patient!
• Fine VF vs asystole - check in multiple leads; turn up gain
• Coarse VF vs polymorphic VT / Torsades - if patient is pulseless, it does not matter - shock both

---

9. ACLS Management (Latest Guidelines - AHA 2020/2023 Update)

Immediate Steps (First 2 Minutes):

1. Confirm cardiac arrest: unresponsive, no normal breathing, no pulse (check <10 seconds)
2. Call for help: activate emergency response, get AED/defibrillator
3. Start CPR immediately - do not wait for equipment
4. Attach monitor/defibrillator while CPR is ongoing

Defibrillation Energy Levels:

CPR Sequence (High-Quality CPR Standards):

1. CPR (2 minutes)
2. Stop CPR → check rhythm → if VF/pVT: shock
3. Immediately resume CPR for 2 minutes (do not check pulse right after shock)
4. After 2 min CPR: check rhythm again
5. Give drugs in next cycle

Drug Therapy:

• Dose: 1 mg IV/IO every 3-5 minutes
• Route: IV or intraosseous (IO); if no IV access, can give via ETT (2-2.5 mg diluted)
• Timing: Give after 2nd shock (or after 1st shock if no IV yet)
• Mechanism: Alpha-1 agonist → vasoconstriction → increases aortic diastolic pressure → improves coronary perfusion pressure → increases likelihood of ROSC
• Note: Beta effects increase myocardial oxygen demand but also increase contractility
• AHA 2020 update: Epinephrine improves ROSC but long-term neurological survival benefit is less clear; still recommended

• First-line antiarrhythmic for shock-refractory VF
• Dose: 300 mg IV bolus (first dose), then 150 mg IV (second dose, if needed)
• Mechanism: Prolongs action potential and refractory period (Class III), also has Class I, II, IV effects
• Given: After 3rd shock (when VF persists despite CPR + 3 shocks + epinephrine)

• Alternative to amiodarone if amiodarone not available or contraindicated
• Dose: 1-1.5 mg/kg IV (first dose), then 0.5-0.75 mg/kg (repeat doses)
• Mechanism: Blocks fast Na+ channels → depresses ectopic pacemakers → Class IB
• Note: Amiodarone is preferred; lidocaine is the backup

• Indicated for: Torsades de Pointes + hypomagnesemia-associated VF
• Dose: 1-2 g IV over 5-20 minutes
• Not used routinely in VF

• Not routine in VF
• Indicated in: pre-existing metabolic acidosis, hyperkalemia, TCA overdose
• Dose: 1 mEq/kg IV; risk is paradoxical intracellular acidosis

• Epinephrine - every 3-5 min (start after 2nd shock)
• Amiodarone - 300 mg after 3rd shock
• Lidocaine - if amiodarone unavailable
• Magnesium - for TdP/hypomagnesemia
• Sodium bicarbonate - only for specific indications

Post-Resuscitation Care (Post-ROSC Bundle):

1. Targeted Temperature Management (TTM):
   • Indicated for comatose patients after ROSC
   • Target temperature: 32-36°C for at least 24 hours
   • Prevents secondary neurological injury from reperfusion
   • Evidence: TTM at 33°C vs 36°C shows similar outcomes; 36°C is now often preferred (more stable hemodynamics)
2. Hemodynamic stabilization:
   • Target MAP >65 mmHg (vasopressors if needed)
   • Avoid hypotension (SBP <90 mmHg worsens outcomes)
   • Optimize heart rate and rhythm
3. Ventilation:
   • Avoid hyperoxia: target SpO2 94-98% (hyperoxia causes reactive oxygen species injury)
   • Avoid hypocapnia: target PaCO2 35-45 mmHg
   • Normocapnia preferred
4. Identify and treat the cause:
   • 12-lead ECG: look for STEMI (requires immediate PCI even if comatose)
   • Echo: assess wall motion, structural disease
   • Labs: electrolytes, ABG, troponin, toxicology screen
   • Consider cardiac catheterization
5. Neuroprognostication:
   • Do not declare neurological prognosis within first 72 hours post-ROSC (TTM and sedation confound exam)
   • Use multimodal approach: clinical exam + EEG + SSEP + brain imaging
6. ICD implantation:
   • Indicated if no reversible cause identified (reduces recurrence risk)
   • Consider after 40+ days of surviving MI (EF <35%)

---

10. Complications and Prognosis

Complications of VF/Resuscitation:

Prognosis:

• In-hospital VF: survival to discharge approximately 20-35% (better than out-of-hospital)
• Out-of-hospital VF: survival to discharge approximately 5-10% overall; up to 40-50% if witnessed + bystander CPR + rapid defibrillation
• Time dependency (Morgan & Mikhail): survival decreases 7-10% for every minute without defibrillation
• Best prognostic factor: Witnessed arrest + bystander CPR + early defibrillation (the "chain of survival")
• Primary VF (early VF in acute MI without pump failure): better prognosis, cardiac function usually preserved
• Secondary VF (with cardiogenic shock/heart failure): very poor prognosis

---

11. Shockable Rhythms: VF vs Pulseless VT

Shockable Rhythms (the two you must know):

• Mechanism: multiple simultaneous reentry circuits
• ECG: chaotic, no QRS
• Cause: ischemia, HCM, channelopathies, electrolyte disorders
• Treatment: unsynchronized shock (defibrillation)

• Mechanism: single or multiple reentry circuits; faster than VT that retains a pulse
• ECG: wide regular QRS complexes at 150-250/min
• Cause: similar to VF; often ischemia
• Treatment: unsynchronized shock (defibrillation - same as VF)

VF vs Pulseless VT Comparison (Exam Table):

• VT with pulse: patient may be alert, hypotensive, or in extremis - may try synchronized cardioversion first
• VF: always pulseless - always needs defibrillation

• TdP: polymorphic VT with QRS amplitude that twists around the baseline ("turning of the points")
• Associated with prolonged QT interval on baseline ECG
• If pulseless TdP: defibrillate (same as VF/pVT)
• If with pulse: magnesium sulfate 1-2 g IV is first-line

---

12. High-Yield MBBS Viva Questions and Answers

• H's: Hypovolemia, Hypoxia, Hydrogen ion (acidosis), Hypo/hyperkalemia, Hypothermia
• T's: Tension pneumothorax, Tamponade (cardiac), Toxins, Thrombosis (pulmonary/coronary)

---

13. High-Yield NEET PG Concepts and Memory Tricks

High-Yield Facts for MCQs:

1. VF = shockable rhythm (along with pVT). Asystole and PEA are NOT shockable.
2. R-on-T phenomenon → triggers VF (PVC falling on T-wave)
3. QT prolongation → predisposes to TdP → degenerates to VF
4. Brugada syndrome: Right bundle branch block pattern + coved ST elevation in V1-V3 → VF risk (especially at night/with fever)
5. Long QT syndrome: Congenital (KCNQ1/HERG mutations) or acquired (drugs: quinidine, sotalol, haloperidol, TCAs) → TdP → VF
6. ICD is the definitive treatment to prevent recurrent VF (not drugs alone)
7. Epinephrine in CPR: improves ROSC but not necessarily long-term neurological survival (AHA 2020)
8. Amiodarone > Lidocaine for shock-refractory VF (multiple RCTs)
9. Hypothermia/TTM post-ROSC: 32-36°C for 24 hours, comatose patients only
10. Wolff-Parkinson-White + AF: rapid conduction via accessory pathway → rates >300/min → VF (avoid digoxin, verapamil - they speed up accessory conduction)

Memory Tricks:

NEET PG Frequently Tested Points:

• Mechanism of VF: reentry (not automaticity)
• ECG of VF: no P, no QRS, no T - just chaos
• First drug in cardiac arrest (VF): epinephrine 1 mg IV every 3-5 min (after 2nd shock)
• Drug for shock-refractory VF: amiodarone 300 mg IV
• Magnesium sulfate is first-line for Torsades de Pointes (not routine VF)
• Post-ROSC TTM target: 32-36°C
• VF within 48h of acute MI with no heart failure = Primary VF = better prognosis
• Defibrillation mechanism: simultaneously makes all cells refractory → allows SA node to resume

---

14. Clinical Case Scenario with Explanation

Case:

Step-by-Step Management:

• "Mr. X, can you hear me?" - No response
• Check carotid pulse for <10 seconds - absent
• No normal breathing (agonal gasps noted)
• ECG = VF pattern
• Diagnosis: VF cardiac arrest in setting of acute inferior STEMI

• Call code blue / activate emergency team
• Begin chest compressions: 100-120/min, depth 5-6 cm, allow full recoil
• Attach defibrillator pads (already on monitor - check position)

• Charge defibrillator: 200 J biphasic
• "Clear!" - ensure no one touching patient
• Deliver shock
• Immediately resume CPR for 2 minutes without checking pulse

• Stop CPR for rhythm check (<10 seconds)
• VF persists on monitor
• Deliver 2nd shock (200-360 J biphasic)
• Resume CPR immediately
• Establish IV access, draw labs
• Intubate/advanced airway

• Epinephrine 1 mg IV - push, followed by 20 mL NS flush
• Continue CPR cycle
• If VF persists after 3rd shock: Amiodarone 300 mg IV bolus
• Epinephrine every 3-5 minutes

• Patient has palpable carotid pulse
• BP: 90/60 mmHg, HR: 70/min in sinus rhythm
• Patient remains comatose

• 12-lead ECG: confirms inferior STEMI
• Emergent coronary angiography + PCI (even if comatose)
• Initiate TTM: target 33-36°C for 24 hours
• Mechanical ventilation: SpO2 94-98%, PaCO2 35-45 mmHg
• BP support with vasopressors to maintain MAP >65 mmHg
• ICU admission, continuous monitoring
• Consider ICD if recurrence risk high

---

15. Flowchart: Diagnosis and Management of VF

PATIENT COLLAPSES
       |
       ↓
ASSESS: Responsive? Breathing? Pulse?
       |
  NO to all ↓
       |
CALL FOR HELP + START CPR (100-120/min, 5-6 cm depth)
       |
       ↓
ATTACH MONITOR/DEFIBRILLATOR
       |
       ↓
ASSESS RHYTHM
       |
    ┌──┴──┐
 SHOCKABLE      NON-SHOCKABLE
(VF or pVT)    (Asystole/PEA)
    |                |
    ↓                ↓
DEFIBRILLATE    CONTINUE CPR
Biphasic: 200J   + Epinephrine
Monophasic: 360J  every 3-5 min
    |            Treat H's and T's
    ↓
IMMEDIATELY RESUME CPR (2 min)
    |
    ↓
CHECK RHYTHM (every 2 min)
    |
    ↓
VF PERSISTS?
    |
    ↓
2nd SHOCK + CPR
    |
    ↓
VF PERSISTS?
    |
    ↓
3rd SHOCK + EPINEPHRINE 1mg IV
    |
    ↓
VF PERSISTS?
    |
    ↓
AMIODARONE 300mg IV + continue CPR-Shock cycles
Repeat Epinephrine every 3-5 min
    |
    ↓
ROSC? ──YES──→ POST-ROSC CARE
  |              - TTM 32-36°C
  NO              - Target MAP >65
  |               - 12-lead ECG
  ↓               - Treat cause
Consider:          - ICU admission
- Double sequential 
  defibrillation (refractory VF)
- Treat reversible causes (H's and T's)
- Sodium bicarbonate if acidosis

---

16. Common Mistakes Students Make in Exam Questions

---

17. University Exam Model Answers

---

5-Mark Answer: "Define VF and describe its ECG features."

• No identifiable P waves (absent atrial activity)
• No QRS complexes (absent organized ventricular activation)
• No T waves
• Baseline shows continuously varying, chaotic, irregular undulations
• Rhythm is completely irregular with no pattern
• Amplitude varies: initially 0.5 mV (coarse VF), declining to 0.2-0.3 mV after 20-30 seconds (fine VF), with minute voltages persisting up to 10 minutes
• Coarse VF: larger deflections, early stage, better response to defibrillation
• Fine VF: small deflections, late stage, can mimic asystole

---

10-Mark Answer: "Describe the pathophysiology, clinical features, and management of Ventricular Fibrillation."

1. Prolonged conduction pathway (dilated heart)
2. Decreased conduction velocity (ischemia, high K+)
3. Shortened refractory period (catecholamines, drugs)

• Unconsciousness within 4-5 seconds
• Apnea (or agonal gasping)
• Absent pulse and heart sounds
• Fixed dilated pupils (if prolonged)
• Cyanosis

1. Confirm arrest; call for help; start high-quality CPR (100-120/min, 5-6 cm depth)
2. Attach defibrillator; charge to 200 J (biphasic) or 360 J (monophasic)
3. Defibrillate; immediately resume CPR for 2 minutes
4. Reassess rhythm every 2 minutes; repeat shock if VF persists
5. Establish IV/IO access; Epinephrine 1 mg IV every 3-5 minutes (after 2nd shock)
6. After 3rd shock: Amiodarone 300 mg IV bolus (or lidocaine 1-1.5 mg/kg)
7. Treat reversible causes (H's and T's)

• Targeted temperature management (32-36°C, 24 hours, comatose patients)
• Hemodynamic stabilization (MAP >65 mmHg)
• Avoid hyperoxia (SpO2 94-98%) and hypocapnia
• Identify cause (12-lead ECG; PCI if STEMI)
• ICD implantation if no reversible cause

---

15-Mark Answer: "Write in detail about Ventricular Fibrillation."

• Ischemic heart disease (most common - acute MI, chronic CAD)
• Cardiomyopathies (HCM, DCM, ARVC)
• Channelopathies (Long QT syndrome, Brugada syndrome, CPVT)
• WPW syndrome with AF
• Commotio cordis (blunt chest trauma during T-wave upstroke)

• Electrolyte disturbances (hypokalemia, hypomagnesemia)
• Drugs (digoxin toxicity, TCAs, cocaine)
• Severe hypoxia, hypothermia
• Electrocution

• Non-uniform refractoriness (patchy recovery of myocardium)
• Slow conduction zones
• Areas of shortened action potential

• Unconsciousness: 4-5 seconds
• Irreversible brain injury: 4-6 minutes
• VF deteriorates from coarse to fine as myocardial ATP is depleted

• No P waves, no QRS complexes, no T waves
• Completely irregular, chaotic undulating waveform
• No isoelectric baseline
• Coarse VF: amplitude >0.2 mV, early stage, responds better to defibrillation
• Fine VF: amplitude <0.2 mV, late stage, mimics asystole
• Rate: indeterminate

• Confirm cardiac arrest (<10 seconds)
• Call for help, activate emergency response
• Start high-quality CPR: 100-120/min, 5-6 cm depth, full recoil, minimize interruptions

• Biphasic: 120-200 J (or 200 J); Monophasic: 360 J
• Pediatric: 2 J/kg (first), 4 J/kg (subsequent)
• Immediately resume CPR for 2 minutes after each shock
• Reassess rhythm every 2 minutes

• Epinephrine 1 mg IV every 3-5 minutes (after 2nd shock): increases coronary perfusion pressure
• Amiodarone 300 mg IV after 3rd shock (if VF persists): prolongs refractory period
• Lidocaine 1-1.5 mg/kg IV: alternative to amiodarone
• Magnesium sulfate 1-2 g IV: for Torsades de Pointes
• Treat reversible causes: H's and T's

• Targeted temperature management (32-36°C, 24 hours)
• Hemodynamic support (MAP >65 mmHg)
• Controlled ventilation (SpO2 94-98%, normocapnia)
• 12-lead ECG; emergent PCI if STEMI
• ICD implantation if no reversible cause

• Hypoxic-ischemic encephalopathy (most serious)
• Post-cardiac arrest syndrome (ischemia-reperfusion injury)
• Recurrent VF (if underlying cause untreated)
• CPR-related: rib fractures, pneumothorax, aspiration

---

Quick Reference Summary Card

---